Furthermore, the minocycline-mediated NLRP3 inflammasome inhibition and its subsequent therapeutic effect in DN was absent in diabetic Nrf2 KO mice (Shahzad et al., 2016b), thereby implicating Nrf2 protection at the level of the inflammasome. This evidence concerns the gene NLRP3 and liver dysplastic nodule.